Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Bristol Myers Squibb Canada (BMS) announced that Health Canada has approved SOTYKTU (deucravacitinib tablets), an oral tablet for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
read more
Gilead Sciences announced that the European Commission (EC) has authorized a new low-dose tablet form of Biktarvy® (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) and an extension of the indication for Biktarvy to treat HIV infection in virologically suppressed children who are at least two years of age and weigh at ...
read more
Although the global digestive health supplements market is expected to grow from $12.74B in 2021 to $13.97B in 2022 at a compound annual growth rate (CAGR) of 9.6%, the Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic–at least in the short term, according to a study from Reportlinker.
read more
Ascletis announced that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin-like protease (3CLpro) for COVID-19.
read more
The binders excipients market size will grow $444.89M from 2021 to 2026, according to a report by Technavio.
read more
Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that it has entered into an agreement to acquire Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and ...
read more
The global opioids market size is expected to reach $25.33 billion by 2030, registering CAGR of 1.2% during the forecast period, according to a report by Research & Markets. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth.
read more
Mason Vitamins has issued a nationwide voluntary recall of the specific lot of Healthy Sense Daily Multiple with Iron and People's Choice Women's Daily Vitamins with Iron due to Vitamin A, Vitamin B12, Vitamin C, Vitamin E and Pantothenic Acid amounts being lower than the declared amount on the label, which was determined during an FDA inspection.
read more
People are embracing a more sedentary lifestyle as the middle class expands and urbanization accelerates, leading to the need for more drugs–especially oral solid dose (OSD) medicines, according to a report by Research & Markets.
read more
The global softgel encapsulation machine market size is set to be valued at $104.5M in 2022 and is projected to grow at a CAGR of 4.3% from 2022 to 2032. The market is anticipated to reach a valuation of $159.6M by 2032.
read more
The probiotic supplements market is expected to grow from$ 6.9B in 2021 to$11.529B by 2028, according to a study by Research & Markets. It is estimated to grow at a CAGR of 7.6% from 2022 to 2028.
Probiotic supplements are live microorganisms available in the form of powders, tablets, capsules, etc.; these supplements are consumed to restore or ...
read more
Ascletis announced that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application of ASC10 for monkeypox indication.
read more
The global food glazing agents market size is expected to reach $4B by 2028, rising at a market growth of 4.5% CAGR during the forecast period, according to a report by Research & Markets.
read more
ProMach, a global packaging machinery company, announced the appointment of Katie Williar to the position of Marketing Supervisor, Pharma business line.Williar is leading initiatives that promote ProMach’s processing and packaging machinery for the pharmaceutical, nutraceutical, biopharmaceutical and personal care industries.
Williar brings 10 ...
read more
The effervescent tablet market was valued at $8,281.52M in 2021 and is expected to reach $5557.08M by 2029, registering a CAGR of 8.20% during the forecast period of 2022 to 2029, according to a report by Data Bridge Market Research.
read more